By Dr. Chinta Sidharthan Reviewed by Benedette Cuffari, M.Sc. Nov 28 2024 Clinical trials in 2024 highlight the expanded benefits of glucagon-like peptide 1-based medicines, extending beyond glucose control and weight loss to address various disorders. Study:  Expanding applications of therapies based on GLP1. Image Credit: MillaF / Shutterstock.com In a recent study published in Nature Reviews Endocrinology , researchers review recent advancements in glucagon-like peptide-1 (GLP-1)-based